BridgeBio Pharma, Inc. Common Stock (BBIO) Price and Market Data
Explore real-time BridgeBio Pharma, Inc. Common Stock (BBIO) price, market cap, trading volume, and price changes. View the live price chart and key reference data.
BridgeBio Pharma, Inc. Common Stock price chart
BridgeBio Pharma, Inc. is a biotechnology company dedicated to discovering, developing, testing, and delivering transformative therapies for patients with genetic diseases. Its late-stage pipeline includes four programs spanning Mendelian disorders, oncology, and gene therapy. A leading program, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Reference
- Exchange
- XNAS
- Sector
- PHARMACEUTICAL PREPARATIONS
- Employees
- 839
- Listed
- 6/27/2019
- Market cap
- $13.375B
- Shares outstanding
- 195,806,242
- Currency
- usd
- Website
- https://www.bridgebio.com